Press Releases Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE

Equities

PLX

US74365A3095

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 11:24:48 2023-03-21 am EDT			5-day change	1st Jan Change
732.5 ^ILa	-.--%		+3.29%	+69.68%

May. 10	Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
May. 10	Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Protalix BioTherapeutics to Present at the 2024 BIO International Convention	May. 30	AQ
Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)	May. 19	PU
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results	May. 13	AQ
Protalix: Q1 Earnings Snapshot	May. 10	AQ
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024	May. 06	AQ
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	Mar. 15	AQ
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	Mar. 08	AQ
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	Feb. 26	AQ
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	Nov. 07	AQ
Protalix: Q3 Earnings Snapshot	Nov. 06	AQ
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	23-10-31	AQ
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23-10-23	PU
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel	23-10-10	AQ
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors	23-09-13	AQ
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-07	AQ
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results	23-08-08	AQ
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)	23-08-07	PU
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference	23-08-02	AQ
Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023	23-08-01	AQ
Protalix BioTherapeutics : PLX Corporate Presentation (May 2023)	23-06-21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE

Equities

PLX

US74365A3095

Press Releases

Filters